You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
華森製藥(002907.SZ):獲得螺旋藻膠囊藥品補充申請批準通知書
格隆匯 02-19 17:38

格隆匯2月19日丨華森製藥(002907.SZ)公佈,公司近日收到國家藥品監督管理局覈準簽發的關於公司產品螺旋藻膠囊的《藥品補充申請批準通知書》,將變更螺旋藻膠囊藥品說明書中安全性等內容。

具體修訂如下:【不良反應】監測數據顯示,本品可見以下不良反應:噁心、嘔吐、胃部不適等。【禁忌】對本品及所含成份過敏者禁用。【注意事項】第3項修訂爲“按照用法用量服用,孕婦應在醫師指導下服用。”第5項修訂爲“過敏體質者慎用。”由“7、兒童必須在成人監護下使用。8、請將本品放在兒童不能接觸的地方。9、如正在使用其他藥品,使用本品前請諮詢醫師或藥師。”修訂爲“7.請將本品放在兒童不能接觸的地方。8.如正在使用其他藥品,使用本品前請諮詢醫師或藥師。”其餘內容不變。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account